Wieduwilt, M., Yin, J., Kour, O., Teske, R., Stock, W., Escherich, C., Yang, J. J., Li, Z., Byrd, K., Doucette, K., Mangan, J., Hall, S., Mims, A., Jamieson, K., Dinner, S., Bseiso, A., Giordano, G., Saygin, C., Uy, G., Litzow, M., Stone, R. (2025). Inotuzumab ozogamicin then blinatumomab for older adults with newly diagnosed, ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Extended follow-up of alliance for clinical trials in oncology A041703 cohort 1 reveals durable remission and survival. Blood. https://doi.org/10.1182/blood-2025-444